News Archive

US Patent Office issues Allowance for APOSEC Patent (10 Oct. 2019)

On Sept. 6, 2019, the United States Patent and Trademark Office issued a Notice of Allowance concerning the US patent application No. 13/140,120 "Pharmaceutical preparation", the patent of APOSEC for the treatment of internal conditions. Aposcience AG expects the patent soon to be granted.

go back to news archive

Latest News
May
27

Approval for clinical phase II study in DFU by German health agency PEI

[more]

Dec
12

Approval for clinical phase II study in DFU by Austrian health agency

[more]